South San Francisco, California (CA) Biological Products, Except Diagnostic Substances Companies

Featured companies
Cell Genesys Inc
500 Forbes Blvd.
South San Francisco CA 94080
(650) 266-3000
Solstice Neurosciences
701 Gateway Boulevard
South San Francisco CA 94080
(650) 243-4400
Genertech Inc
1 Dna Way
South San Francisco CA 94080
(650) 225-1000
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Evotec (Us) Inc
385 Oyster Point Boulevard # 1
South San Francisco CA 94080
(650) 228-1400
Genentech Inc
400 Grandview Drive
South San Francisco CA 94080
(650) 952-1100
Revmab Biosciences Usa Inc
458 Carlton Court
South San Francisco CA 94080
(650) 952-0110
Second Genome Inc
349 Allerton Avenue
South San Francisco CA 94080
(408) 718-0648
Yenzym Antibodies LLC
337 Littlefield Avenue
South San Francisco CA 94080
(650) 583-1031
Laboratory Skin Care Inc
300 Utah Avenue # 110
South San Francisco CA 94080
(650) 373-0450
Whereorg has 11 results under Biological Products, Except Diagnostic Substances Companies in South San Francisco, CA.

Narrow down the browsing criteria below to see more companies.

Other locations for category Biological Products, Except Diagnostic Substances


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020